Joana Leite Silva

Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register

Elsa Vieira‐Sousa, Mónica Eusébio, Pedro Ávila-Ribeiro et al. · The Journal of Rheumatology · 2019 · 26 citations

Medicine, Pharmacology, Pharmacotherapy +17

Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

José Marona, Alexandre Sepriano, Santiago Rodrigues-Manica et al. · RMD Open · 2020 · 19 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +11

Tocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor in rheumatoid arthritis patients who discontinued a first TNF inhibitor.

Daniela Santos‐Faria, José Tavares‐Costa, Mónica Eusébio et al. · PubMed · 2020 · 14 citations

Medicine, Pharmacology, Pharmacotherapy +15